New Triglyceride-Glucose-Frailty Index Shows Prognostic Value in Cardiometabolic Disease
Personalized briefing
Discovery of the day · Diabetes
Evaluative performance of triglyceride-glucose-frailty index versus surrogate insulin resistance indices for advanced cardiovascular-kidney-metabolic syndrome, cardiometabolic multimorbidity, and mortality: the role of estimated glomerular filtration rate
Dear Dr. Vijay Viswanathan, this is your personalized scientific intelligence briefing — curated for your work in Diabetes.
Key finding
Medicine · Diabetes · Cardiometabolic
Discovery of the day
This study evaluates the performance of a novel triglyceride-glucose-frailty index against established surrogate insulin resistance markers for predicting advanced cardiovascular-kidney-metabolic (CKM) syndrome, cardiometabolic multimorbidity, and mortality. Researchers found that incorporating frailty status into the triglyceride-glucose index enhanced its predictive accuracy, with estimated glomerular filtration rate playing a modifying role in the index’s performance across patient subgroups. For clinical practice, these findings suggest that integrating frailty assessment with metabolic indices could improve risk stratification in patients with diabetes and cardiometabolic complications, offering a more refined tool for identifying high-risk individuals who might benefit from intensified management strategies.
Novelty
92%
Rigor
87%
Significance
91%
Validity
85%
Clarity
78%
Advertisement
GroupRFQ — join group deals on lab & medical equipment. Pool orders, unlock volume pricing. See open deals →
Your briefing is personalized based on your selected fields, keywords, and research interests.
